Dudediligence.

Lipocine Inc

LPCNNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$3.5MDec ’24$93,864Mar ’25$622,849Jun ’25$114,574Sep ’25$1.1MDec ’25$119,397Mar ’26$190,099Jun ’26
Net income, by quarter
−$2.2MSep ’24$1.8MDec ’24−$1.9MMar ’25−$2.2MJun ’25−$3.2MSep ’25−$2.4MDec ’25−$3.7MMar ’26−$2.6MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$16.1M$500,000−$2.9M$11.2M$2.0M
Operating income$3.1M−$12.1M−$17.9M−$1.2M−$10.4M
Net income−$634,399−$10.8M−$16.4M$8,352−$9.6M
Operating cash flow−$4.4M−$12.0M−$11.9M−$1.2M−$9.8M
Free cash flow−$4.4M−$12.1M−$11.9M−$1.3Mnone on file
Cash$3.0M$3.1M$4.8M$6.2M$5.2M
Debt$2.3Mnone on filenone on filenone on filenone on file
Shares outstanding88.3M5.2M5.3M5.3M6.2M